BACPHARPharmaceuticals
Bacil Pharma Ltd — Balance Sheet
₹47.73
-1.10%
Bacil Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.00 | — | — | — | — |
| Ordinary Shares Number | 0.59 Cr | 0.59 Cr | 0.59 Cr | 0.59 Cr | — |
| Share Issued | 0.59 Cr | 0.59 Cr | 0.59 Cr | 0.59 Cr | — |
| Total Debt | 0.16 Cr | 0.10 Cr | 0.02 Cr | 0.03 Cr | — |
| Tangible Book Value | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Invested Capital | 25.60 Cr | 1.31 Cr | 1.12 Cr | 1.26 Cr | — |
| Working Capital | 2.74 Cr | -0.06 Cr | 0.20 Cr | 0.27 Cr | — |
| Net Tangible Assets | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Common Stock Equity | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Total Capitalization | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Total Equity Gross Minority Interest | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Stockholders Equity | 25.43 Cr | 1.21 Cr | 1.10 Cr | 1.22 Cr | — |
| Other Equity Interest | 11.46 Cr | -5.31 Cr | -5.43 Cr | -5.30 Cr | — |
| Capital Stock | 13.97 Cr | 6.53 Cr | 6.53 Cr | 6.53 Cr | — |
| Common Stock | 13.97 Cr | 6.53 Cr | 6.53 Cr | 6.53 Cr | — |
| Total Liabilities Net Minority Interest | 0.17 Cr | 0.11 Cr | 0.03 Cr | 0.05 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Liabilities | 0.17 Cr | 0.11 Cr | 0.03 Cr | 0.05 Cr | — |
| Other Current Liabilities | 9000.00 | 24000.00 | 10000.00 | 16000.00 | — |
| Current Debt And Capital Lease Obligation | 0.16 Cr | 0.10 Cr | 0.02 Cr | 0.03 Cr | — |
| Current Debt | 0.16 Cr | 0.10 Cr | 0.02 Cr | 0.03 Cr | — |
| Payables | 41000.00 | 59870.00 | 13910.00 | 0.01 Cr | — |
| Accounts Payable | 41000.00 | 35880.00 | 4360.00 | 0.01 Cr | — |
| Total Assets | 25.60 Cr | 1.33 Cr | 1.13 Cr | 1.27 Cr | — |
| Total Non Current Assets | 22.69 Cr | 1.27 Cr | 0.90 Cr | 0.96 Cr | — |
| Other Non Current Assets | -1000.00 | — | — | — | 1000.00 |
| Non Current Deferred Taxes Assets | 0.05 Cr | 0.06 Cr | 0.12 Cr | 0.11 Cr | — |
| Investmentin Financial Assets | 21.36 Cr | 0.61 Cr | 0.24 Cr | 0.24 Cr | — |
| Net PPE | 0.00 | 62340.00 | 82290.00 | 0.01 Cr | — |
| Current Assets | 2.91 Cr | 0.05 Cr | 0.23 Cr | 0.32 Cr | — |
| Other Current Assets | 0.05 Cr | 0.01 Cr | 91000.00 | 96000.00 | — |
| Cash Cash Equivalents And Short Term Investments | 2.86 Cr | 0.04 Cr | 0.22 Cr | 0.31 Cr | — |
| Cash And Cash Equivalents | 2.86 Cr | 0.04 Cr | 0.03 Cr | 0.23 Cr | — |
| Net Debt | — | 0.06 Cr | — | — | 0.08 Cr |
| Retained Earnings | — | -5.31 Cr | -5.43 Cr | -5.30 Cr | -5.14 Cr |
| Non Current Deferred Taxes Liabilities | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Provisions | — | 85000.00 | 59000.00 | 17700.00 | 90747.00 |
| Total Tax Payable | — | 23990.00 | 9550.00 | 15477.00 | 10981.00 |
| Available For Sale Securities | — | 0.61 Cr | 0.24 Cr | 0.24 Cr | 0.24 Cr |
| Accumulated Depreciation | — | -0.05 Cr | -0.05 Cr | -0.05 Cr | -0.04 Cr |
| Gross PPE | — | 0.06 Cr | 0.06 Cr | 0.06 Cr | 0.06 Cr |
| Machinery Furniture Equipment | — | 0.06 Cr | 0.06 Cr | 0.06 Cr | 0.06 Cr |
| Prepaid Assets | — | 60620.00 | 60620.00 | 60620.00 | 0.06 Cr |
| Taxes Receivable | — | 45660.00 | 30650.00 | 35179.00 | 70294.00 |
| Accounts Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Financial | — | 0.04 Cr | 0.03 Cr | 0.23 Cr | 0.10 Cr |
| Other Short Term Investments | — | — | 0.19 Cr | 0.08 Cr | 0.14 Cr |
| Other Non Current Liabilities | — | — | — | — | 1.00 |
| Long Term Debt And Capital Lease Obligation | — | — | — | — | 0.00 |
| Long Term Debt | — | — | — | — | 0.00 |
| Other Receivables | — | — | — | — | 130.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bacil Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.